Currency in INR
| Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2025) | Next year (2026) |
|---|
| No. of analysts | 0 | 0 | 4 | 4 |
| Avg. Estimate | 0 | 0 | 48.25 | 54.9 |
| Low estimate | 0 | 0 | 45.8 | 50.8 |
| High estimate | 0 | 0 | 51.3 | 61.4 |
| Year ago EPS | N/A | N/A | 26.35 | 48.25 |
| Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2025) | Next year (2026) |
|---|
| No. of analysts | 4 | 0 | 4 | 4 |
| Avg. Estimate | 37.92B | N/A | 37.92B | 41.71B |
| Low estimate | 37.33B | N/A | 37.33B | 40.69B |
| High estimate | 38.46B | N/A | 38.46B | 42.18B |
| Year ago sales | 34.54B | N/A | 34.54B | 37.92B |
| Sales growth (year/est) | 9.80% | N/A | 9.80% | 10.00% |
| Earnings history | Invalid Date | Invalid Date | Invalid Date | 31/03/2023 |
|---|
| Est. EPS | N/A | N/A | N/A | 11.29 |
| Actual EPS | N/A | N/A | N/A | 7.88 |
| Difference | N/A | N/A | N/A | -3.41 |
| Surprise % | N/A | N/A | N/A | -30.20% |
| EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2025) | Next year (2026) |
|---|
| Current estimate | 0 | 0 | 48.25 | 54.9 |
| 7 days ago | 11.66 | 0 | 48.25 | 54.9 |
| 30 days ago | 11.66 | 0 | 45.3 | 51.1 |
| 60 days ago | 11.66 | 0 | 45.3 | 51.1 |
| 90 days ago | 11.66 | 0 | 45.3 | 51.1 |
| EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2025) | Next year (2026) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | 4 | 4 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | GLAXO.NS | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | 83.10% | N/A | N/A | N/A |
| Next year | 13.80% | N/A | N/A | N/A |
| Next 5 years (per annum) | 15.00% | N/A | N/A | N/A |
| Past 5 years (per annum) | 2.02% | N/A | N/A | N/A |
